Predictive Factors in Response to Inhaled Corticoids in Chronic Cough

Not Applicable

• Conditions: Healthy
• Interventions: Drug: Budesonide novolizer; Drug: Placebo

• Registration Number: NCT02715167
• Lead Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Brief Summary

The hypothesis is that a high fractional exhaled nitric oxide can predict the response to inhaled corticoids in chronic cough.

Detailed Description

Not available

Study Timeline

• Status Verified: 2016-03
• Study Start: 2016-03
• Study First Submitted: 2016-03-04
• Study First Submitted QC: 2016-03-16
• Last Update Submitted: 2016-03-16
• Study First Posted: 2016-03-22
• Last Update Posted: 2016-03-22
• Primary Completion: 2016-04
• Study Completion: 2017-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• chronic cough

Exclusion Criteria

• active smoker
• treated by corticoids during the previous month
• use of angiotensin-converting-enzyme inhibitor

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group Budesonide	Budesonide novolizer	Inhaled corticoids
Group Placebo	Placebo	Placebo by inhalation

Primary Outcome Measures

Name	Time	Method
Leicester cough questionnaire	5 minutes